SCHOTT Pharma AG & Co. KGaA (1SXP) — Tangible Net Worth Ratio
SCHOTT Pharma AG & Co. KGaA (1SXP) has a Tangible Net Worth Ratio of 99.9% as of September 2024. This metric is calculated by deducting intangible assets (€1.12 Million) from net assets (€792.27 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore 1SXP net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
SCHOTT Pharma AG & Co. KGaA Tangible Net Worth Ratio (2020–2024)
This chart shows how SCHOTT Pharma AG & Co. KGaA's Tangible Net Worth Ratio has changed across 5 annual periods from 2020 to 2024. As of September 2024, the ratio stands at 99.9%, reflecting net assets of €792.27 Million with intangible assets of €1.12 Million EUR. For live market cap and overall valuation, see SCHOTT Pharma AG & Co. KGaA stock valuation.
Annual Tangible Net Worth Ratio for SCHOTT Pharma AG & Co. KGaA (2020–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for SCHOTT Pharma AG & Co. KGaA from 2020 to 2024, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore 1SXP capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 99.9% | €792.27 Million | €1.12 Million | €1.44 Billion | ▲ +0.1 pp |
| 2023 | 99.8% | €692.18 Million | €1.45 Million | €1.23 Billion | ▲ +0.1 pp |
| 2022 | 99.7% | €709.04 Million | €1.92 Million | €1.20 Billion | ▲ +0.1 pp |
| 2021 | 99.6% | €419.42 Million | €1.72 Million | €739.89 Million | ▲ +0.4 pp |
| 2020 | 99.2% | €315.66 Million | €2.61 Million | €596.02 Million | — |